Detalhe da pesquisa
1.
Management of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimens.
Br J Haematol
; 192(2): 292-299, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33216980
2.
Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia.
Ann Hematol
; 103(6): 2181-2183, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38427058
3.
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population.
Haemophilia
; 25(1): 67-74, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30427567
4.
Suppression of different classes of somatic mutations in Arabidopsis by vir gene-expressing Agrobacterium strains.
BMC Plant Biol
; 15: 210, 2015 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-26307100
5.
Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia.
Sci Rep
; 14(1): 8404, 2024 04 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38600158
6.
Metabolic crosstalk between stromal and malignant cells in the bone marrow niche.
Bone Rep
; 18: 101669, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36909665
7.
Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia.
Cell Transplant
; 32: 9636897231198178, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37706453
8.
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia.
Blood Adv
; 6(2): 652-663, 2022 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34625794
9.
Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells.
Mol Cancer Res
; 18(4): 529-536, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31915234
10.
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide.
Cancer Med
; 9(8): 2603-2610, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32059085
11.
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia.
Cell Death Dis
; 10(10): 736, 2019 09 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31570693
12.
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
Front Immunol
; 9: 1357, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29963052
13.
Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia.
Blood Cancer J
; 12(1): 22, 2022 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35102152